Cargando…
RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells
Tumor escape mechanisms for immunotherapy include deficiencies in antigen presentation, diminishing adaptive CD8(+) T cell antitumor activity. Although innate natural killer (NK) cells are triggered by loss of MHC class I, their response is often inadequate. To increase tumor susceptibility to both...
Autores principales: | Zhang, Zhengkui, Kong, Xiangjun, Ligtenberg, Maarten A., van Hal-van Veen, Susan E., Visser, Nils L., de Bruijn, Beaunelle, Stecker, Kelly, van der Helm, Pim W., Kuilman, Thomas, Hoefsmit, Esmée P., Vredevoogd, David W., Apriamashvili, Georgi, Baars, Beau, Voest, Emile E., Klarenbeek, Sjoerd, Altelaar, Maarten, Peeper, Daniel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245005/ https://www.ncbi.nlm.nih.gov/pubmed/35688159 http://dx.doi.org/10.1016/j.xcrm.2022.100655 |
Ejemplares similares
-
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling
por: Apriamashvili, Georgi, et al.
Publicado: (2022) -
The (re)discovery of tumor-intrinsic determinants of immune sensitivity by functional genetic screens
por: Vredevoogd, D.W., et al.
Publicado: (2021) -
Proteomics and
Phosphoproteomics Profiling of Drug-Addicted
BRAFi-Resistant Melanoma Cells
por: Li, Bohui, et al.
Publicado: (2021) -
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
por: Boshuizen, Julia, et al.
Publicado: (2020) -
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance
por: Boshuizen, Julia, et al.
Publicado: (2023)